📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
OXYGENTA PHARMACEUTICAL LIMITEDOXYGENTAPHPharmaceuticals
Open
45.3
High
48.95
Low
45.3
Close
47.99
Volume
2717
Exchange
bse
Time
01-Apr-2026

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Oxygenta Pharmaceutical is  
None
Estimated Stoploss of Oxygenta Pharmaceutical is ₹  
45.3
Oxygenta Pharmaceutical has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Oxygenta Pharmaceutical is  
Unpredictableℹ
. 

Trend

Oxygenta Pharmaceutical is in  
Sideways trendℹ
. 
Price of Oxygenta Pharmaceutical is  
Downℹ
 by  

7.43

%. 
Target
Buy @ 

45

Sell @ 

62.2

Current @ 

47.99

Volume

The trade volumes of Oxygenta Pharmaceutical have become  
Deficientℹ
The volume trend for Oxygenta Pharmaceutical is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Oxygenta Pharmaceutical is  

Down

 by  

81.06

% 

Valuation

The current market price of Oxygenta Pharmaceutical is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 83cr and total assets worth ₹ 83cr, the balance sheet of Oxygenta Pharmaceutical is:  
Balancedℹ
. 
Cashflow
Oxygenta Pharmaceutical has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

9.52% i.e. ₹ 2cr earned in operatingℹ
52.38% i.e. ₹ 11cr spent in investingℹ
38.1% i.e. ₹ 8cr earned in financingℹ
0% in otherℹ
Oxygenta Pharmaceutical has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

38.24% i.e. ₹ 13cr spent in operatingℹ
11.76% i.e. ₹ 4cr spent in investingℹ
50% i.e. ₹ 17cr earned in financingℹ
0% in otherℹ
Income
The income of Oxygenta Pharmaceutical is  

₹ 14cr

 and  

Loss

 is :  

₹ 4cr

(*Sep 2025)

Oxygenta Pharmaceutical Losses decreased by:  

33.33

% and Income is Down by:  

6.67

% 

(*Sep 2025)

The income of Oxygenta Pharmaceutical is  

₹ 15cr

 and  

Loss

 is :  

₹ 6cr

(*Jun 2025)

Oxygenta Pharmaceutical Losses increased by:  

200

% and Income is Down by:  

69.39

% 

(*Jun 2025)

The income of Oxygenta Pharmaceutical is  

₹ 49cr

 and  

Loss

 is :  

₹ 2cr

(*Mar 2025)

Oxygenta Pharmaceutical Losses decreased by:  

33.33

% and Income is Up by:  

48.48

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.